NASDAQ:ACRS

Aclaris Therapeutics Stock Predictions

Healthcare > Medical - Diagnostics & Research

Buy ACRS

*Your capital is at risk

$4.42

-0.210 (-4.54%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ACRS Prediction Chart

ACRS Predictions History

Latest community submissions for ACRS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Camille Rao @CamilleRao.126010	Nov 4, 2019	Bullish	$1.81	X	—	0
PumpTheseNumbers Pro	Oct 30, 2019	$1.87 +1.63%	$1.84	X	98.37%	1
WoodsYoung125476	Oct 30, 2019	$7.60 +313.04% Unrealistic Excluded from avg	$1.84	X	0.00%	0
NameNotImportant Pro	Apr 29, 2019	$6.72 -1.47%	$6.82	X	98.53%	1
NameNotImportant Pro	Apr 22, 2019	$5.84 -0.68%	$5.88	X	99.32%	3
JS Pro	Feb 5, 2018	$21.14 +5.59%	$20.11	V	94.90%	0
Metallica @Metallica.18524	Feb 5, 2018	$21.01 +4.95%	$20.11	V	95.50%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACRS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ACLARIS THERAPEUTICS

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by